INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025)
INVO Fertility (IVF) posted quarterly Preferred Stock Liabilities of $4.0 million for Q1 2025, down 46.64% quarter-over-quarter from $7.5 million in Q4 2024.
INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends
INVO Fertility (IVF) has reported Preferred Stock Liabilities for 2 consecutive years, with $4.0 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Preferred Stock Liabilities changed N/A year-over-year to $4.0 million; the TTM figure through Mar 2025 stood at $4.0 million (changed N/A YoY), while the FY2024 annual figure was $7.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities fell to $4.0 million in Q1 2025 per IVF's latest filing, from $7.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $7.5 million in Q4 2024 and bottomed at $4.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 10.12 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 7.46 Mn |